Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.55 Analyst target: $3.50 Upside: 536.36%
BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
See the full interactive analysis & chart →Informational only — not investment advice.